News

Walgreens has agreed to be taken private, but the agreement is a bit complex. There's a reason to buy the stock despite the ...
Even during its best run-up of the decade, it only rose 160%. For whatever reason, this stock just doesn’t move much. Therefore, the biggest downside to owning Walgreens stock is the opportunity cost.
Let's Talk Money! with Joseph Hogue, CFA on MSN1d

Buy This Stock BEFORE It Goes on Sale

Is Walgreens Boots Alliance (WBA) a buy? Analyze the stock, dividend yield, debt, and Cencora impact to make an informed ...
Meanwhile, Walgreens' stock price is around $11.20 per share, which means there's around $0.25 per share in possible gains here for investors trying to arbitrage the takeover.
The average Walgreens Boots Alliance price target is $46, implying 19.29% upside potential.The TakeawayIt's easy to find valid reasons to invest in Walgreens, if you're willing to look for them.
Walgreens stock is plunging, now down roughly 65% YTD. Walgreens's financials indicate a gross profit but far too much SG&A. Additionally, 25% of stores are unprofitable, and profitability is ...
Walgreens Boots Alliance (WBA -0.66%) stock looks to have finally received some much-needed bullishness from investors. The stock was jumping last week on rumors that a private equity firm may be ...
Per the consensus price target of Wall Street analysts, shares of Walgreens Boots Alliance (WBA -0.40%) are set to gain 23% within a year. But given the stock's decline of 27% over the last three ...
Furthermore, Walgreens recorded a $5.8 billion impairment charge related to its VillageMD investment in the previous quarter. Overall, Walgreens stock looks undervalued at its current levels of ...
The company revealed that Walgreens Specialty Pharmacy has broadened its limited distribution drug (LDD) portfolio to cover ...
Walgreens Boots Alliance has seen a significant decline in stock price, with my position down 75%, leading me to reaffirm my "Hold" rating. WBA's dividend yield is 10.5%, but sustainability is ...
In the three months ended November 30, Walgreens' revenue increased 7.5% year over year to $39.5 billion, driven by growth across all business segments. Its earnings per share (EPS) declined 22.7% ...